Pituitary Adenomas Flashcards
1
Q
4 Ways They Present
A
- Mass effect - macroadenomas esp
- Hypopituitarism (can be adenoma or multiple other causes)
- Hormone excess - Prolactin, GH, ACTH, TSH (hyper-secretion is almost always adenoma)
- Incidental finding on imaging
2
Q
Categorization of Pituitary Adenomas
A
- 70% hyper-secretion, 25% null-cell adenoma (no apparent hormone), 2% plurihormonal
- By Specific Hormone
- Prolactin secreting most common
- Then null cell adenoma or gonadotropin (FSH, LH, alpha subunit)
- GH/ACTH 10% ea
- Rare - TSH or plurihormonal
- By size
- Micro < 1 cm - less likely to cause hypopituitarism; rarely progress
- Macro > 1 cm - 50% have mass hypopituitary effect; more aggressive
3
Q
Possible Consequences of Macroadenoma
A
- Can cause CN palsies or rare temporal seizures if lateral extension into cavernous sinuses or temporal lobe
- If stretch dura above - headaches
- Bitemporal field defects if affect optic chiasm
- CSF rhinorrhea if downward
4
Q
GH Hypersecretion Presentation
A
- Soft tissue growth - coarsening of facial features and enlargement of hands/feet (inc ring size, shoe size, hat size), arthralgias (OA from cartilage growth), median nerve compressed w/ soft tissue swelling, stimulates sweat glands, diabetogenic, sodium retention, organs enlarged (including thyroid - goiter- higher rate thyroid cancer), sleep apnea (enlarged tongue), cardiomyopathy from enlarged heart, inc lipids in blood inc CV risk, widely spaced teeth, colon polyps
- Often insidious / dx missed for many yrs
- Often macroadenoma - check for visual defects; may have headaches
- 20% co-secrete prolactin (sometimes secrete TSH)
5
Q
GH Tumor Tx
A
- surgery (transphenoidal adenomectomy) then recheck IGF-1 3 mo after
- If persistent - use meds
- Octreotide - somatostain analog (GH secretion inhibitor); monthly IM injection (GI upset, impaired glucose tolerance, cholethiasis)
- Lantreotide - monthly subQ injection
- Pegvisomant - GH analog that prevents receptor dimerization to dec IGF-1 synthesis; no tumor shrinkage but less GI effects and better diabetic control
- Cabergoline - dopamine agonist; best for patients w/ prolactin co-secretion; cheaper and oral; can be added to others
- If still persists - gamma knife radiosurgery (as long as >3-5 mm from optic chiasm)
6
Q
Prolactinoma Presentation
A
inappropriate lactation, oligomenorrhea or amenorrhea in women, hypogonadism in men, delayed puberty
-B/c prolactin dec GnRH - dec sex hormones
7
Q
Prolactinemia Dx Based on Amount
A
- > 200 almost always prolactinoma
- 100-200 probably prolactinoma (could also be compression of stalk)
- < 100 could be primary hypothyroid or pregnancy or using neuroleptics or micro prolactinoma
8
Q
Prolactinoma Tx
A
- only one treated w/ meds first then surgery
- Dopamine agonist - bromocriptine (shorter half life for preg), cabergoline (preferred more potent/effective and only twice weekly dose)
- Dec PRL DNA synthesis so tumor shrinkage (often visual and reproductive problems resolve)
- Drugs bind D2 receptor - G alpha inhibitory subunit –> dec adenylyl cyclase –> dec cAMP –> dec prolactin gene transcription
9
Q
ACTH Excess
A
- Causes 75% of all Cushing Syndrome from extra cortisol (another lecture)
- Usually ACTH secreting adenomas are small (40% not seen on MRI)
- 30s - 50s; women > men
- High mortality from CVD and inc risk infections
- Tx - surgery is first-line, also gamma knife, meds
10
Q
TSH Excess
A
- RARE (<1%)
- Present w/ classic hyperthyroid symptoms but no extrathyroid manifestations as seen in Graves’; no TSH suppression (this is tip-off)
- Commonly co-secretion of alpha subunit or GH / hyperprolactinemia
- Tend to be large and aggressive
- Often delay tx b/c misdiagnose as thyroid problem
- Tx - surgery and irradiation; may use octreotide to normalize thyroxine and cause tumor shrinkage if needed (octreotide dec TSH production)
11
Q
2 Types of Clinically Non-Functioning Pituitary Adenomas
A
1- FSH/LH Hyper-secretion
- Usually elevated FSH/LH means gonadal failure BUT may be due to pituitary tumor - Usually discovered due to mass effect from growth - headaches, visual disturbance
2- Null Cell Adenoma
- 10% spont regress so “wait and see” approach if no visual field defect (do annual MRI for monitoring)
FOR BOTH - no meds; perform surgery only if symptomatic